Marshall Islands vs Syria: Share of one-year-olds vaccinated against Haemophilus influenzae type B
Marshall Islands
72.0%
in 2024
Syria
73.0%
in 2024
Marshall Islands rank
161st
Syria rank
158th
Share of one-year-olds vaccinated against Haemophilus influenzae type B over time
- Marshall Islands
- Syria
How they compare
Syria currently reports 73.0% against 72.0% in Marshall Islands, a difference of 1.0%.
The two have swapped places 2 times across 24 shared years of data; in 2001 it was Syria ahead.
Marshall Islands ranks 161st and Syria ranks 158th of 192 countries.
Across the 3 decades both report, Marshall Islands averaged higher in 2 and Syria in 1.
Head to head by decade
| Decade | Marshall Islands | Syria | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 71.6% | 81.0% | 9.4% | Syria |
| 2010s | 70.7% | 61.7% | 9.0% | Marshall Islands |
| 2020s | 71.8% | 64.2% | 7.6% | Marshall Islands |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of one-year-olds vaccinated against haemophilus influenzae type b, Marshall Islands or Syria?
- Syria, at 73.0% against 72.0% in Marshall Islands as of 2024.
- What is the difference in share of one-year-olds vaccinated against haemophilus influenzae type b between Marshall Islands and Syria?
- 1.0%, with Syria ahead.
- How many years of comparable data are there for Marshall Islands and Syria?
- 24 years are reported by both, from 2001 to 2024.
- How do Marshall Islands and Syria rank globally for share of one-year-olds vaccinated against haemophilus influenzae type b?
- Marshall Islands ranks 161st and Syria ranks 158th of 192 countries.
- Where does this data come from?
- WHO & UNICEF (2025); UN, World Population Prospects (2024) – processed by Our World in Data, published as Share of one-year-olds vaccinated against Haemophilus influenzae type B. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Share of one-year-olds who have had three doses of Haemophilus influenzae type b vaccine in a given year.